Biotech, Pharma Cos. Eye Impact Of DOJ's Foreign Data Rule
By Dan McKay · November 5, 2024, 10:06 AM EST
Facing deadline pressure, biotechnology and pharmaceutical organizations are moving fast to analyze whether a new U.S. Department of Justice proposal to restrict data-sharing with China and five other countries will disrupt...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login